$SNDX 3 SEC Filings

Filed On	Filing
16 May 2025	Form 3: Botwood Nicholas A.j., Head of R&D, CMO Holds 23,400 shares of Common Stock
16 May 2024	Form 3: Rizo Aleksandra, Director No securities owned
12 Apr 2023	Form 3: Gallagher Neil, President, Head of R&D No securities owned
05 Dec 2022	Form 3: Sabus Steve M, Chief Commercial Officer No securities owned
15 Jun 2022	Form 3: Goldan Keith A., Chief Financial Officer No securities owned
03 Mar 2022	Form 3: Madigan Catherine, Chief Medical Officer No securities owned
04 Nov 2021	Form 3: Nolte Alexander, Chief Accounting Officer
17 Sep 2021	Form 3: Huber Martin H. Jr., Director No securities owned
13 Jul 2020	Form 3: Karydas Daphne, Chief Financial Officer
27 Sep 2018	Form 3: Jarrett Jennifer, Director No securities owned
27 Sep 2018	Form 3: Meury William, Director No securities owned
08 Dec 2017	Form 3: Bvf Partners L P/IL, 10% owner and 6 others Holds 1,603,416 shares of Common Stock, $0.0001 par value per share
31 Mar 2017	Form 3: Katkin Keith, Director No securities owned
05 Jan 2017	Form 3: Legault Pierre, Director No securities owned
02 Mar 2016	Form 3: Dp Vi Associates, L.p., 10% owner and 4 others
02 Mar 2016	Form 3: Domain Partners VI, L.p., 10% owner and 4 others
02 Mar 2016	Form 3: Domain Partners VIII, L.p., 10% owner and 5 others
02 Mar 2016	Form 3: Dp Viii Associates, L.p., 10% owner and 5 others
02 Mar 2016	Form 3: Domain Associates, 10% owner and 7 others Holds 13,564 shares of Common Stock
02 Mar 2016	Form 3: Mpm BioVentures Iv Qp Lp, 10% owner and 9 others

Comments